For research use only ยท Not for human or animal consumption
// Neuropeptide & Melanocortin

Melanotan-1 Research Guide

[Nle4, D-Phe7]-alpha-MSH, known by the nonproprietary name afamelanotide, an MC1R agonist. Covers the 1980 discovery and the approved implant’s clinical trials.

4Sources
3FAQs
4Min read
For research use only. Not for human consumption.
01

What is Melanotan-1?

Melanotan-1 is the 13-amino-acid alpha-melanocyte-stimulating hormone (ฮฑ-MSH) analogue [Nle4, D-Phe7]-ฮฑ-MSH. Its international nonproprietary name is afamelanotide. It was first described in 1980 as a highly potent ฮฑ-melanotropin with prolonged biological activity (Sawyer et al., 1980).

Afamelanotide is described as a first-in-class melanocortin-1 receptor (MC1R) agonist (Kim and Garnock-Jones, 2016).

02

Research areas studied

The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.

How the analogue was designed

Researchers noticed that heating ฮฑ-MSH under alkaline conditions prolonged its activity and partly racemized the amino acids at positions 4 (methionine) and 7 (phenylalanine). Synthesizing the analogue with norleucine at position 4 and D-phenylalanine at position 7 reproduced that prolonged activity (Sawyer et al., 1980).

In vitro findings

In the 1980 study, [Nle4, D-Phe7]-ฮฑ-MSH resisted degradation by serum enzymes and showed sharply increased activity in a frog skin bioassay, in mouse melanoma adenylate cyclase activation and in mouse melanoma cell tyrosinase activity. It was 26 times as potent as ฮฑ-MSH in the adenylate cyclase assay, and the authors proposed it as a molecular probe for studying melanotropin receptors (Sawyer et al., 1980).

Clinical research on the approved implant

Two randomized, placebo-controlled phase 3 trials (74 patients in the EU and 94 in the US) studied a controlled-release implant in erythropoietic protoporphyria (EPP), a rare light-sensitivity disorder. Both reported more pain-free time in direct sunlight than with placebo, with mostly mild adverse events (Langendonk et al., 2015). A 2016 review reports headache and implant-site reactions as common adverse reactions (Kim and Garnock-Jones, 2016).

Regulatory status and limits of the evidence

Afamelanotide is approved as Scenesse, a controlled-release implant, in the EU for prevention of phototoxicity in adults with EPP (Kim and Garnock-Jones, 2016), and by the FDA in 2019. That approval applies to the manufactured implant for EPP, not to research vials. A dermatology review describes reports of mole changes and melanoma case reports associated with unregulated melanotan use, while noting that conclusive causal evidence is lacking (Habbema et al., 2017).

03

Storage and handling

Like most research peptides, Melanotan-1 is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.

When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.

04

Quality and COA

Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.

05

Melanotan-1 FAQ

Is Melanotan-1 the same as afamelanotide?

Yes. Afamelanotide is the international nonproprietary name for [Nle4, D-Phe7]-ฮฑ-MSH, the compound known as Melanotan-1.

Which receptor does Melanotan-1 act on?

It is a melanocortin-1 receptor (MC1R) agonist.

How is Melanotan-1 different from Melanotan-2?

Melanotan-1 is a linear 13-amino-acid analogue that acts at MC1R. Melanotan-2 is a smaller cyclic peptide that acts at several melanocortin receptors.

07

References

  1. Sawyer TK, Sanfilippo PJ, Hruby VJ, et al. (1980). Proc Natl Acad Sci U S A. PubMed 6777774
  2. Kim ES, Garnock-Jones KP (2016). Am J Clin Dermatol. PubMed 26979527
  3. Langendonk JG, Balwani M, Anderson KE, et al. (2015). N Engl J Med. PubMed 26132941
  4. Habbema L, Halk AB, Neumann M, et al. (2017). Int J Dermatol. PubMed 28266027

For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.

Get 15% Off Your First Order

Join the Zero Zero Collection list for restock alerts, new COAs and member pricing. Research use only.